Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease : Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease

Aim: To investigate the efficacy of systemic corticosteroids in treatment for Post-COVID-19 Interstitial Lung Disease.Method: Method: In this multi-centre, prospective, randomised controlled open label clinical trial, patients are divided into two arms: standard treatment arm and standard plus systemic corticosteroid arm. After twelve weeks; clinical, functional, and radiological improvement will being assessed as primary outcomes..

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

ClinicalTrials.gov - (2023) vom: 10. Okt. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
COVID-19
Lung Diseases
Lung Diseases, Interstitial
Phase: Phase 4
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

Source: Link to the current ClinicalTrials.gov record., First posted: August 3, 2021, Last downloaded: ClinicalTrials.gov processed this data on October 18, 2023, Last updated: October 18, 2023

Study ID:

NCT04988282
STERCOV-ILD

Veröffentlichungen zur Studie:

fisyears:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG007790260